 Zidovudine AZT treatment patients human immunodeficiency virus type evaluation effectiveness clinical practice patterns use effectiveness zidovudine therapy clinical practice observational cohort study patients human immunodeficiency virus type infection patients months zidovudine AZT therapy patients full-dosage zidovudine mg/d dosage mg/d follow-up number able full-dosage zidovudine therapy months months Thirty-five patients dosage reductions days adverse outcome death opportunistic infection Overall adverse outcomes dosage reductions patients previous dosage change baseline cytopenias time dosage reductions adverse outcomes patients reductions zidovudine dosage results full-dosage zidovudine therapy patients human immunodeficiency virus clinicians pessimistic treatment outcomes dosage reductions